Pendal Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $194K | Sell |
13,543
-6,241
| -32% | -$89.3K | ﹤0.01% | 482 |
|
|
2022
Q3 | $505K | Sell |
19,784
-46,257
| -70% | -$1.18M | ﹤0.01% | 344 |
|
|
2022
Q2 | $1.88M | Buy |
66,041
+12,073
| +22% | +$343K | 0.02% | 215 |
|
|
2022
Q1 | $1.9M | Buy |
53,968
+35,330
| +190% | +$1.25M | 0.02% | 263 |
|
|
2021
Q4 | $781K | Sell |
18,638
-29,798
| -62% | -$1.25M | 0.01% | 369 |
|
|
2021
Q3 | $2.38M | Sell |
48,436
-4,651
| -9% | -$228K | 0.02% | 209 |
|
|
2021
Q2 | $2.22M | Buy |
53,087
+43,885
| +477% | +$1.83M | 0.02% | 234 |
|
|
2021
Q1 | $328K | Buy |
+9,202
| New | +$328K | ﹤0.01% | 468 |
|